Pricing

Log inSign up

VistaGen Therapeutics

3 followers

‌

VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need.

Industries

Education, Pharmaceutical

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Shawn K. Singh
CEO & Director

Shawn K. Singh

Collapse
Reid Adler
Chief Legal Officer
Cindy Anderson
CFO
Jessica R. Haskell
VP, Associate General Counsel & Secretary
Mark J. Ginski
SVP, Head of CMC
Allen Cato III
SVP, Development Operations
Trisha Fitzmaurice
SVP, Human Resources
Joshua Prince
VP, Strategic Insights & Analytics
Greg Weilersbacher
VP, Quality Assurance
Louis Monti
VP, Translational Medicine
Ross A. Baker
VP, Global Medical Affairs
Mark Flather
VP, Investor Relations
Mark A. McPartland
VP, Corporate Development
Ester Salmán
VP, Clinical Research
ID
Imogene Dunn
VP, Biostatistics
Michelle Peters Wellington
VP, Communications
Margie Schneider
Director, Clinical Supply Chain

Teams

+2

Leadership Team

5 members

+3

Clinical and Medical Team

6 members

Legal and Compliance

3 members

HS
KC

Project Management

3 members

Regulatory and Quality Affairs

3 members

Similar companies

Rimsys

2 followers

Bristol-Myers Squibb

179 followers

Karyopharm Therapeutics

12 followers

Charlie Health

5 followers

Apprenti

3 followers

The Modern College of Design

1 follower

Sowell Management

44 followers

Artiva Biotherapeutics

1 follower

Shyft Group

3 followers

Novartis

226 followers

VIRIXENE

117 followers

Explore companies